I quite like this quote from Merchant on patients electing to stay on NTI164 “In all my years of biotech investing I have never seen a circumstance where people elect (and the authorities encourage) to stay on a trial after being on it for +90 weeks!
Ann: Rett Syndrome Patients to Receive NTI164 for 52 Weeks, page-4
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.3¢ |
Change
0.001(1.61%) |
Mkt cap ! $64.09M | |||
| Open | High | Low | Value | Volume |
| 6.4¢ | 6.4¢ | 6.3¢ | $21.57K | 340.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 121099 | 6.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.3¢ | 29523 | 1 |
View Market Depth
| Last trade - 14.09pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.3¢ |
Change
0.001 ( 1.61 %) |
||||
| Open | High | Low | Volume | ||
| 6.3¢ | 6.3¢ | 6.3¢ | 78093 | ||
| Last updated 12.18pm 07/06/2024 ? | |||||
| NTI (ASX) Chart |